BridgeBio Pharma (BBIO) Interest & Investment Income (2018 - 2026)
BridgeBio Pharma (BBIO) reported Interest & Investment Income of $6.2 million for Q1 2026, up 15.99% on a YoY basis from $5.4 million in Q1 2025, and up 44.18% sequentially from $4.3 million in Q4 2025.
BridgeBio Pharma (BBIO) Interest & Investment Income (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of Interest & Investment Income data on file, last reported at $6.2 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 15.99% year-over-year to $6.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.8 million (up 25.9% YoY), and the FY2025 full-year result was $19.9 million, up 15.1% from the prior year.
- Interest & Investment Income climbed to $6.2 million in Q1 2026, from $4.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q1 2026 to a low of -$251000.0 in Q1 2022.
- A 5-year average of $2.7 million and a median of $3.3 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 147.31% in 2022 and jumped 18668.97% in 2025, its largest moves.
- Tracing BBIO's Interest & Investment Income over 5 years: stood at $4.1 million in 2022, then jumped by 36.31% to $5.6 million in 2023, then fell by 16.05% to $4.7 million in 2024, then decreased by 7.5% to $4.3 million in 2025, then jumped by 44.18% to $6.2 million in 2026.
- Business Quant data shows BBIO's Interest & Investment Income at $6.2 million in Q1 2026, $4.3 million in Q4 2025, and $6.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | BridgeBio Pharma | 16.41 Bn | 15.47 Bn | 184.58 Mn | 6.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.25 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 75,000.00 |
| Mar 31, 2023 | 316,000.00 |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | -44,000.00 |
| Mar 31, 2022 | -251,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 93,000.00 |